GE HEALTHCARE TECHNOLOGY
GEHCNASDAQ🏆 #374 by market capEarnings Oct 28 · PreUS Equity
——
Quote unavailableTrack GEHC
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$34.25B
Mid Cap
📈Revenue Growth (YoY)
6.5%
Slowing
📊Gross Margin
39.5%
Healthy
💵FCF Margin
7.4%
Moderate
⚖️P/S Ratio
1.5x
Cheap
Otter Score
76
Strong
GE HEALTHCARE TECHNOLOGY
GEHCAnalyst Ratings
Total
19
Raised
0
Lowered
1
Avg PT
$78.80
H / L
$93 / $65
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
BTIG | Reiterated | Buy | 2026-10-28 | $79.00 | — |
Needham | Reiterated | Buy | 2026-10-05 | $93.00 | — |
Citigroup | Reiterated | Neutral | 2026-10-05 | — | — |
UBS | Reiterated | Neutral | 2026-07-31 | $67.00 | — |
Evercore ISI Group | Reiterated | Outperform | 2026-07-30 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-07-30 | $87.00 | — |
JP Morgan | Reiterated | Neutral | 2026-04-30 | — | — |
Goldman Sachs | Downgraded | Buy → Neutral | 2026-04-30 | $65.00 | — |
Barclays | Reiterated | Equal Weight | 2026-04-30 | $85.00 | — |
Piper Sandler | Reiterated | Overweight | 2026-04-17 | $88.00 | — |
Mizuho | Reiterated | Outperform | 2026-04-13 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2026-02-05 | $85.00 | — |
Stifel | Reiterated | Buy | 2026-02-05 | — | — |
B of A Securities | Reiterated | Neutral | 2026-01-05 | — | — |
Jefferies | Reiterated | Buy | 2025-12-11 | $105.00 | — |
Argus Research | Reiterated | Buy | 2024-04-01 | $110.00 | — |
Oppenheimer | Reiterated | Outperform | 2023-05-16 | $85.00 | — |
Redburn Partners | Reiterated | Buy | 2023-01-19 | — | — |
Edward Jones | Reiterated | Hold | 2023-01-04 | — | — |
Institution
BTIG
Reiterated · Buy · 2026-10-28
$79.00
—
Needham
Reiterated · Buy · 2026-10-05
$93.00
—
Citigroup
Reiterated · Neutral · 2026-10-05
—
—
UBS
Reiterated · Neutral · 2026-07-31
$67.00
—
Evercore ISI Group
Reiterated · Outperform · 2026-07-30
—
—
Wells Fargo
Reiterated · Overweight · 2026-07-30
$87.00
—
JP Morgan
Reiterated · Neutral · 2026-04-30
—
—
Goldman Sachs
Downgraded · Buy → Neutral · 2026-04-30
$65.00
—
Barclays
Reiterated · Equal Weight · 2026-04-30
$85.00
—
Piper Sandler
Reiterated · Overweight · 2026-04-17
$88.00
—
Mizuho
Reiterated · Outperform · 2026-04-13
—
—
Morgan Stanley
Reiterated · Equal Weight · 2026-02-05
$85.00
—
Stifel
Reiterated · Buy · 2026-02-05
—
—
B of A Securities
Reiterated · Neutral · 2026-01-05
—
—
Jefferies
Reiterated · Buy · 2025-12-11
$105.00
—
Argus Research
Reiterated · Buy · 2024-04-01
$110.00
—
Oppenheimer
Reiterated · Outperform · 2023-05-16
$85.00
—
Redburn Partners
Reiterated · Buy · 2023-01-19
—
—
Edward Jones
Reiterated · Hold · 2023-01-04
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space